Industry Developments
Estonia
BMI believes that the use of generic drugs in Estonia is set to increase, following the introduction of a decree aimed at promoting the substitution of generics for prescription drugs....
2010-03-18Russia
Pharmaceutical prices in Russia and Ukraine have been under intense scrutiny since the latter part of 2008, as a result of negative economic conditions, associated currency devaluations...
2010-03-17Lithuania
BMI believes Lithuania's pricing and reimbursement environment is becoming increasingly negative for major pharmaceutical companies and patients. A Government of the Republic of Lithuania...
2010-03-16Latvia
Latvian pharmaceutical company Olainfarm has announced plans to open a representative office in Bangkok during 2010, while also expanding into Central Asian markets. BMI considers...
2010-03-15Slovenia
Slovenian pharmaceutical company Lek, a division of Novartis's generic arm Sandoz, has opened a new US$3.8mn biopharmaceutical production facility to produce biosimilar epoetin alfa....
2010-03-12Czech Republic
The presence of countries from BMI's Emerging Europe Region in the Pharmaceutical Research and Manufacturers of America (PhRMA)'s Special 301 Submission 2010 remains largely equivalent...
2010-03-11Slovakia
The next update to Slovakia's medicine price list is due in April 2010, with the Ministry of Health aiming to reference 90% of marketed products. This update is expected to bring...
2010-03-10Slovenia
The Slovenian government approved a draft Health Services Act in March 2010, laying the groundwork for system reform in the country. The act introduces a number of reforms that will...
2010-03-09
